advantages of Nanostructured Lipid Carriers in buccal administration

Introduction

Nanostructured Lipid Carriers (NLCs) are advanced drug delivery systems that have garnered significant attention for their potential in various routes of administration, including buccal delivery. These carriers are composed of a blend of solid and liquid lipids, which provide a partially crystallized lipid matrix. This unique structure offers several advantages over traditional lipid-based carriers, making NLCs a promising option for enhancing drug delivery and therapeutic efficacy.

Key Insights

Enhanced Drug Loading and Stability:
- NLCs offer improved drug loading capacity and stability compared to other lipid-based carriers, such as solid lipid nanoparticles (SLNs) .
Sustained and Controlled Drug Release:
- NLCs provide a sustained and controlled drug release profile, which can enhance therapeutic outcomes by maintaining drug levels within the therapeutic window for extended periods .
Improved Bioavailability:
- NLCs significantly enhance the bioavailability of poorly soluble drugs, making them more effective for oral and buccal administration .
Mucoadhesive Properties:
- When incorporated into mucoadhesive hydrogels, NLCs exhibit desirable rheological and mucoadhesive properties, increasing the residence time on the buccal mucosa and improving therapeutic efficacy.
Biocompatibility and Non-toxicity:
- NLCs are composed of biocompatible and biodegradable materials, making them safe for various routes of administration, including buccal delivery .
Ease of Preparation and Scalability:
- The preparation methods for NLCs are relatively simple and scalable, facilitating their production for commercial applications .

Conclusion

Nanostructured Lipid Carriers (NLCs) offer several advantages for buccal administration, including enhanced drug loading and stability, sustained and controlled drug release, improved bioavailability, and excellent mucoadhesive properties. Their biocompatibility, non-toxicity, and ease of preparation further underscore their potential as effective drug delivery systems. These attributes make NLCs a promising option for improving therapeutic outcomes in buccal drug delivery applications.

Advantages of Nanostructured Lipid Carriers in buccal administration

Summary

Introduction

Key Insights

Conclusion

Sources and full results

Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen.

Mucoadhesive buccal hydrogels with lipid nanoparticles show potential for increased drug retention and ease of application in the buccal mucosa, potentially benefiting therapeutic efficacy.

Nanostructured lipid carriers for site-specific drug delivery.

Nanostructured lipid carriers (NLC) offer enhanced drug loading capacity, flexibility in drug release, and improved stability, making them ideal for site-specific drug delivery in pharmaceutical and cosmetic industries.

Nanostructured lipid carriers system: Recent advances in drug delivery

Nanostructured lipid carriers (NLC) offer enhanced drug loading capacity, prevention of drug expulsion, and flexibility for modulating drug release, making them a versatile delivery system for various routes of administration in pharmaceutical technology.

Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin.

Nanostructured lipid carriers (NLCs) significantly improve the oral bioavailability and prolong the antihyperlipidemic effect of simvastatin, offering promising drug delivery systems for hyperlipidemia management.

Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.

Nanostructured lipid carriers significantly improve the oral bioavailability of etoposide and show promising potential for oral delivery of VP16.

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

Solid lipid nanoparticles and nanostructured lipid carriers show promise as novel drug delivery systems due to their ease of manufacturing, biocompatibility, and biodegradability, but their effectiveness depends on the route of administration.

Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.

Nanostructured lipid carriers (Nanoject) show potential for sustained intravenous delivery of artemether, offering higher antimalarial activity, longer duration, and higher survival rate compared to the marketed injectable formulation.

Nanostructured lipid carriers: versatile oral delivery vehicle

Nanostructured lipid carriers (NLCs) improve oral drug bioavailability and therapeutic functionality by incorporating bioactives, offering a versatile and economical oral delivery method.

Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine.

Nanostructured lipid carriers-loaded dissolving microneedles effectively enhance transdermal delivery and controlled local administration of aconitine, effectively inhibiting inflammation and improving arrhythmia in adjuvant-induced arthritis model rats.

Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.

Nanostructured lipid carriers with higher oleic acid content show faster drug release and potential for oral administration, with improved drug encapsulation efficiency and faster drug release rate.

Try another search